氧氯丙嗪

氧氯丙嗪结构式
氧氯丙嗪结构式
品牌特惠专场
常用名 氧氯丙嗪 英文名 Oxychlorpromazine
CAS号 969-99-3 分子量 334.86400
密度 1.35g/cm3 沸点 502.6ºC at 760 mmHg
分子式 C17H19ClN2OS 熔点 115°
MSDS N/A 闪点 257.8ºC

[Simultaneous determination of chlorpromazine and promethazine and their main metabolites by capillary electrophoresis with electrochemiluminescence].

Se Pu 30(9) , 938-42, (2012)

Based on the phenomenon that each of chlorpromazine (CPZ), promethazine (PMZ), chlorpromazine sulfoxide (CPZSO) and promethazine sulfoxide (PMZSO) could enhance the electrochemiluminescence (ECL) intensity of tris(2,2'-bipyridyl) ruthenium, a novel and sensit...

Free radical production by chlorpromazine sulfoxide, an ESR spin-trapping and flash photolysis study.

Photochem. Photobiol. 44(1) , 5-10, (1986)

Involvement of erythrocyte skeletal proteins in the modulation of membrane fluidity by phenothiazines.

Biochemistry 26(25) , 8133-7, (1987)

The effects of phenothiazines (chlorpromazine, chlorpromazine sulfoxide, and trifluoperazine) and antimitotic drugs (colchicine and vinblastine) on the erythrocyte membrane have been investigated. Chlorpromazine and trifluoperazine induced a dose-dependent in...

Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites.

Ther. Drug Monit. 9(3) , 358-65, (1987)

A new high-performance liquid chromatographic (HPLC) procedure for the simultaneous determination of chlorpromazine and its six metabolites, namely, 7-hydroxy-chlorpromazine, N-monodesmethyl-chlorpromazine, 7-hydroxy-N-monodesmethyl-chlorpromazine, chlorproma...

Therapeutic monitoring of chlorpromazine II: Pitfalls in whole blood analysis.

Ther. Drug Monit. 7(4) , 472-7, (1985)

Pooled whole blood from healthy volunteers was spiked with pure, synthetic chlorpromazine, chlorpromazine sulfoxide, or chlorpromazine N-oxide and then made alkaline with either sodium hydroxide or sodium carbonate. The addition of alkali causes lysis of red ...

False negative result for amphetamines on the Triage Drug of Abuse panel? The cause of the unusual phenomenon with experimental analyses.

Int. J. Legal Med. 123(3) , 247-52, (2009)

On-site drug screening devices are widely used today for their simple test procedures and instantaneous results. Among other devices, a Triage Drug of Abuse panel is considered to be highly reliable for its high specificity and sensitivity of abused drugs. Al...

Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human blood.

Ther. Drug Monit. 8(1) , 37-41, (1986)

Chlorpromazine (CPZ), chlorpromazine sulfoxide (CPZSO), and chlorpromazine N-oxide (CPZNO) were each incubated (37 degrees C), for various timed intervals up to 60 min, with pooled human whole blood. Plasma and red blood cells were then separated and analyzed...

Postsynaptic inhibitory effects of phenothiazines at cholinergic synapses may not involve calmodulin.

Naunyn Schmiedebergs Arch. Pharmacol. 333(4) , 454-6, (1986)

Treatment of frog cutaneous-pectoris nerve-muscle preparations with calmidazolium (R 24571), a calmodulin-inhibitor, at concentrations of 2 X 10(-7) mol/l and 5 X 10(-7) mol/l had no discernable effect on MEPP amplitude. 10(-6) mol/l calmidazolium caused a sm...

Phenothiazines mimic the action of cAMP in potentiating slow inward current in a bursting molluscan neuron.

Brain Res. 273(2) , 384-6, (1983)

Trifluoperazine and chlorpromazine, blockers of calmodulin action, potentiate slow inward current in molluscan neurons identically to the action of cAMP. The sulfoxide derivative of chloropromazine does not appreciably bind to calmodulin and also fails to enh...

Chlorpromazine, but not chlorpromazine sulphoxide, stimulates transmitter release from motor nerve terminals.

Brain Res. 437(2) , 397-401, (1987)

Treatment of frog neuromuscular preparations with chlorpromazine (5 mumol/l) resulted in a marked rise in miniature endplate potential (MEPP) frequency of greater than 100% within 30 min, and an increase in evoked transmitter release (quantal content 5-15) of...